Rahim A. Remtulla

Rahim Remtulla practices at UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Rahim Remtulla's NPI, 1881899128, was assigned on June 18, 2007. Rahim Remtulla holds Pennsylvania license MD453838.

Rahim Remtulla's primary practice is UPMC Magee-Womens Hospital, at 300 Halket Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 641-4010.

Rahim Remtulla's primary practice is UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Rahim Remtulla is also affiliated with UPMC Presbyterian. The medical group on file is UPMC Hillman Cancer Center. Dmand AI also links Rahim Remtulla to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rahim Remtulla practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Rahim Remtulla's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Rahim Remtulla is licensed in Pennsylvania.

CMS data shows 987 Medicare services from Rahim Remtulla across 7 procedure codes in 2024, for 269 Medicare patients. Medicare paid $62,669 for them.

CMS counts 269 Medicare patients who saw Rahim Remtulla in 2024. The largest group is 65 to 74, with 132 patients. 74% of them have high cholesterol, and 71% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rahim Remtulla's median patient age at 71, with 53% women.

In 2024, Rahim Remtulla wrote 1,002 Medicare Part D claims for 235 patients. 78% of them were for generic drugs. CMS names the drug for 771 of them, across 22 drugs with 11 or more claims each, at $949,749 in total drug cost. In 2023, CMS named 719 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 65 out of 100 for Rahim Remtulla for performance year 2024, reported as part of a group. Rahim Remtulla accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 64 general payments to Rahim Remtulla from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 83% of the total. Siemens Medical Solutions USA, Inc. paid the most, $23,600.